Why the study?
Does surgical implantation of epicardial LV electrodes improve clinical and echocardiographic outcomes in heart failure patients with failed transvenous lead placement?
Population
17 patients with symptomatic heart failure despite optimal medical therapy, in whom transvenous LV lead…
Design
Cohort
Follow-up
6.3 ± 1.13 months
Key result
Surgical epicardial left ventricular lead implantation in patients with failed transvenous access was safe and resulted in an improved mean ejection fraction of 29.4% at 6 months.
Authors
Loading...
May support epicardial leads after transvenous failure; leaves open need for randomized confirmation.
Observational (n=17)
Does surgical implantation of epicardial LV electrodes improve clinical and echocardiographic outcomes in heart failure patients with failed transvenous lead placement?
Surgical epicardial LV lead implantation via mini-thoracotomy is a safe and effective alternative for cardiac resynchronization therapy in patients with failed transvenous lead placement, improving ejection fraction and functional class.
Gür et al. (2013) conducted an observational in Symptomatic heart failure with failed transvenous LV lead implantation (n=17). Surgical epicardial left ventricular lead implantation was evaluated on Ejection fraction at 6 months. Surgical epicardial left ventricular lead implantation in patients with failed transvenous access was safe and resulted in an improved mean ejection fraction of 29.4% at 6 months.